Skip to main content
SpringerLink
Log in

Cushing’s Disease

  • Chapter
The Pituitary Gland

Part of the book series: Clinical Surveys in Endocrinology ((CSED,volume 1))

  • 231 Accesses

Abstract

Cushing’s disease, or pituitary-dependent hypercortisolism, is an entity characterized by the development of hypercortisolism secondary to inappropriate ACTH secretion by the pituitary gland. Since the original description by Harvey Cushing in 1932,1there have been remarkable strides in our understanding of the pathophysiology, laboratory diagnosis and therapeutic modalities of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cushing H: The basophillic adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins 50:137, 1932.

    Google Scholar 

  2. Taylor HC, Velasco ME, Brodkey JS: Remission of pituitary dependent Cushing’s disease after removal of nonneoplastic pituitary gland. Arch Intern Med 140:1366, 1980.

    PubMed  CAS  Google Scholar 

  3. Liddle GW: Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 20:1539, 1960.

    PubMed  CAS  Google Scholar 

  4. Orth DN, Liddle GW: Results of treatment in 108 patients with Cushing’s syndrome. N Engl J Med 285:243, 1971.

    PubMed  CAS  Google Scholar 

  5. Krieger DT, Luria M: Plasma ACTH and Cortisol responses to TRF, vasopressin or hypoglycemia in Cushing’s disease and Nelson’s syndrome. J Clin Endocrinol Metab 44:361, 1977.

    PubMed  CAS  Google Scholar 

  6. Krieger DT: Medical treatment of Cushing’s disease. In Tolis G (ed): Clinical neuroendocrinology: A Pathophysiological Approach. Raven, New York, 1979, p. 423.

    Google Scholar 

  7. Pieters GFFM, Smals AGH, Benraad TJ, et al: Plasma Cortisol response to thyrotropinreleasing hormone and luteinizing hormone-releasing hormone in Cushing’s disease. J Clin Endocrinol Metab 48:874, 1979.

    PubMed  CAS  Google Scholar 

  8. Aronin N, Krieger DT: Sustained remission of Nelson’s syndrome after stopping cyproheptadine treatment. N Engl J Med 302:453, 1980.

    PubMed  CAS  Google Scholar 

  9. Jones MT, Birmingham M, Gillham B, et al: The effect of cyproheptadine on the release of corticotrophin releasing factor. Clin Endocrinol (Oxf) 10:203, 1979.

    CAS  Google Scholar 

  10. Lankford HV, Tucker HSG, Blackard WG: A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing’s disease. N Engl J Med 305:1244, 1981.

    PubMed  CAS  Google Scholar 

  11. Lamberts SWJ, Klijn, JGM, de Quijada M, et al: The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing’s disease and Nelson’s syndrome. J Clin Endocrinol Metab 51:307, 1980.

    PubMed  CAS  Google Scholar 

  12. Carey RM, Varma SK, Drake CR Jr, et al: Ectopic secretion of corticotropin releasing factor as a cause of Cushing’s syndrome. N Engl J Med 311:13, 1984.

    PubMed  CAS  Google Scholar 

  13. Liddle GW: Pathogenesis of glucocorticoid disorders. Am J Med 53:638, 1972.

    PubMed  CAS  Google Scholar 

  14. Krieger DT, Glick SM: Sleep EEG stages and plasma growth hormone concentration in states of endogenous and exogenous hypercortisolemia or ACTH elevation. J Clin Endocrinol Metab 39:986, 1974.

    PubMed  CAS  Google Scholar 

  15. Boggan JE, Tyrrell, JB, Wilson CB: Transsphenoidal microsurgical management of Cushing’s disease. J Neurosurg 59:195, 1983.

    PubMed  CAS  Google Scholar 

  16. Hardy J: Cushing’s disease: 50 years later. Can J Neurol Sci 9:375, 1982.

    PubMed  CAS  Google Scholar 

  17. Lamberts SWJ, De Lange SA, Stefanko SZ: Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing’s disease: Differences in the regulation of hormone secretion. J Clin Endocrinol Metab 54:286, 1982.

    PubMed  CAS  Google Scholar 

  18. Ludecke DK, Schabet M, Saeger W: In vitro secretion of adenoma and anterior lobe cells in two typical cases of Cushing’s disease. Neurosurgery 12:549, 1983.

    PubMed  CAS  Google Scholar 

  19. Ludecke DK, Westphal M, Schabet M, et al: In vitro secretion of ACTH, β-endorphin and β-lipotropin in Cushing’s disease and Nelson’s syndrome. Horm Res 13:259, 1980.

    PubMed  CAS  Google Scholar 

  20. Suda T, Tozawa F, Mouri T, et al: Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing’s disease. J Clin Endocrinol Metab 56:1094, 1983.

    PubMed  CAS  Google Scholar 

  21. Lamberts SWJ, Klijn JGM, Quijada M, et al: The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing’s disease and Nelson’s syndrome. J Clin Endocrinol Metab 51:307, 1980.

    PubMed  CAS  Google Scholar 

  22. Ishibashi M, Yamaji T: TRH stimulation and dopaminergic and antiserotonergic inhibition of ACTH release from cultured pituitary adenoma tissues of Nelson’s syndrome. Program of the Sixth International Congress of Endocrinology, Melbourne, Australia, 1980 ,p. 407.

    Google Scholar 

  23. Fitzgerald PA, Aron DC, Findling JW: Cushing’s disease: Transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J Clin Endocrinol Metab 54:413, 1982.

    PubMed  CAS  Google Scholar 

  24. Jeffcoate WJ, Dauncey S, Selby C: Restoration of dexamethasone suppression by incomplete adenomectomy in Cushing’s disease. Clin Endocrinol (Oxf) 23:193, 1985.

    CAS  Google Scholar 

  25. Burch WM: Cushing’s disease. Arch Intern Med 145:1108, 1985.

    Google Scholar 

  26. Van Cauter E, Refetoff S: Evidence for two subtypes of Cushing’s disease based on the analysis of episodic Cortisol secretion. N Engl J Med 312:1343, 1985.

    PubMed  Google Scholar 

  27. Orth DN, Holscher MA, Wilson MG, et al: Equine Cushing’s disease: Plasma immunoreactive proopiolipomelanocortin peptide and Cortisol levels basally and in response to diagnostic tests. Endocrinology 110:1430, 1982.

    PubMed  CAS  Google Scholar 

  28. Neumann PE, Horoupian DS, Goldman JE, et al: Cytoplasmic filaments of Crooke’s hyaline change belong to the cytokeratin class. Am J Pathol 116:214, 1984.

    PubMed  CAS  Google Scholar 

  29. Felix IA, Horvath E, Kovacs K: Crook’s hyalinization in corticotroph cell adenomas of the human pituitary: A histological, immunocytological and electron microscopic study of three cases. Acta Neurochir 58:235, 1981.

    CAS  Google Scholar 

  30. Ross EJ, Marshall JP, Friedman M: Cushing’s syndrome: Diagnostic criteria. Q J Med 35:149, 1966.

    PubMed  CAS  Google Scholar 

  31. Bertagna C, Orth DN: Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951–1978). Am J Med 71:855, 1981.

    PubMed  CAS  Google Scholar 

  32. Urbanic RC, George JM: Cushing’s disease-18 years experience. Medicine (Baltimore) 60:14, 1981.

    CAS  Google Scholar 

  33. Ross J, Linch DC: Cushing’s syndrome-killing disease: Discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2:646, 1982.

    PubMed  CAS  Google Scholar 

  34. Biglieri EG, Hane S, Slaton PE Jr, et al: In vivo and in vitro studies of adrenal secretions in Cushing’s syndrome and primary aldosteronism. J Clin Invest 42:516, 1963.

    PubMed  CAS  Google Scholar 

  35. Krakoff L, Nicolis G, Amsel B: Pathogenesis of hypertension in Cushing’s syndrome. Am J Med 58:216, 1975.

    PubMed  CAS  Google Scholar 

  36. Mendlowitz M, Gitlow S, Noftchi N: Work of digital vasoconstriction produced by infused norepinephrine in Cushing’s syndrome. J Appl Physiol 13:252, 1958.

    PubMed  CAS  Google Scholar 

  37. Gabrilove JL: Neurologic and psychiatric manifestations of the classic endocrine syndromes. Res Pub ARNMD 43:419, 1966.

    CAS  Google Scholar 

  38. Spillane JD: Nervous and mental disorders in Cushing’s syndrome. Brain 74:72, 1951.

    PubMed  CAS  Google Scholar 

  39. Glaser GH: Psychotic reactions induced by corticotrophin (ACTH) and cortisone. Psychosom Med 15:280, 1953.

    PubMed  CAS  Google Scholar 

  40. Starkman M, Schteingart DE: Neuropsychiatric manifestations of patients with Cushing’s syndrome. Arch Intern Med 141:215, 1981.

    PubMed  CAS  Google Scholar 

  41. Terenius L, Wahlstrom A, et al: Increased CSF levels of endorphins in chronic psychosis. Neurosci Lett 3:157, 1976.

    PubMed  CAS  Google Scholar 

  42. Khaleeli AA, Edwards RHT, Gohil K, et al: Corticosteroid myopathy: A clinical and pathological study. Clin Endocrinol (Oxf) 18:155, 1983.

    CAS  Google Scholar 

  43. Khaleeli AA, Betteridge DJ, Edwards RHT, et al: Effect of treatment of Cushing’s syndrome on skeletal muscle structure and function. Clin Endocrinol (Oxf) 19:547, 1983.

    CAS  Google Scholar 

  44. Cryer P, Ludmerer KM, Kissane JM (eds): Bruising and thin skin in a 54 year old woman. Am J Med 79:101, 1985.

    Google Scholar 

  45. Ferguson JK, Donald RA, Weston TS, et al: Skin thickness in patients with acromegaly and Cushing’s syndrome and response to treatment. Clin Endocrinol (Oxf) 18:347, 1983.

    CAS  Google Scholar 

  46. A. Imura H, Matsukusa S, Yamamoto H, et al: Studies on ectopic ACTH-producing tumors II. Clinical, biochemical features of 30 cases. Cancer 35:1430, 1975.

    PubMed  CAS  Google Scholar 

  47. Gold EM: The Cushing’s syndromes: Changing views of diagnosis and treatment. Ann Intern Med 90:829, 1979.

    PubMed  CAS  Google Scholar 

  48. Teates CD: Steroid-induced mediastinal lipomatosis. Radiology 96:501, 1970.

    PubMed  CAS  Google Scholar 

  49. Santini LC, Williams JL: Mediastinal widening (presumable lipomatosis) in Cushing’s syndrome. N Engl J Med 284:1357, 1971.

    PubMed  CAS  Google Scholar 

  50. Van De Putte LB, Wagenaar JPM, San KH: Paracardiac lipomatosis in exogenous Cushing’s syndrome. Thorax 28:653, 1973.

    PubMed  Google Scholar 

  51. Lipson SJ, Naheedy MII, Kaplan MM, et al: Spinal stenosis caused by epidural lipomatosis in Cushing’s syndrome. N Engl J Med 302:36, 1980.

    PubMed  CAS  Google Scholar 

  52. Lee M, Lekias J, Gubby SS, et al: Spinal cord compression by extradural fat after renal transplantation. Med J Aust 1:201, 1975.

    PubMed  CAS  Google Scholar 

  53. George WE, Wilmott M, Greenhouse A, et al: Medical management of steroid-induced epidural lipomatosis. N Engl J Med 308:316, 1983.

    PubMed  Google Scholar 

  54. Sowerbutts JG: Some uses for presacral oxygen insufflation. J Faculty Radiol 10:201, 1959.

    Google Scholar 

  55. Christian CD Jr, Schneider RP: Fatty tumor of the liver in a patient with Cushing’s syndrome. Arch Intern Med 743:1605, 1983.

    Google Scholar 

  56. Chajek T, Romanoff H: Cushing’s syndrome with cyclical edema and periodic secretion of corticosteroids. Arch Intern Med 136:441 ,1976.

    PubMed  CAS  Google Scholar 

  57. Findling JW, Tyrrell B, Aron DC, et al: Fungal infections in Cushing’s syndrome. Ann Intern Med 95:392, 1981.

    PubMed  CAS  Google Scholar 

  58. Dal Bo Zanon R, Fornasiero L, Boscaro M, et al: Increased factor VIII associated activities in Cushing’s syndrome: A probable hypercoaguable state. Thromb Hemost 47:116, 1982.

    Google Scholar 

  59. Didolkar MS, Bescher AR, et al: Natural history of adrenal cortical carcinoma. Cancer 47:2153, 1981.

    PubMed  CAS  Google Scholar 

  60. Hutter AM, Kayhoe DE: Adrenal cortical carcinoma-clinical features of 138 patients. Am J Med 41:572, 1966.

    PubMed  Google Scholar 

  61. Fachnie JD, Zafar MS, Mellinger R, et al: Pituitary carcinoma mimics the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 50:1062, 1980.

    PubMed  CAS  Google Scholar 

  62. Liddle GW, Nicholson WE, Island DP, et al: Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res 25:283, 1969.

    PubMed  CAS  Google Scholar 

  63. Singer W, Kovacs K, Ryan N, et al: Ectopic ACTH syndrome: Clincopathological correlations. J Clin Pathol 31:591, 1978.

    PubMed  CAS  Google Scholar 

  64. Williams ED, Morales AM, et al: Thyroid carcinoma and Cushing’s syndrome. J Clin Pathol 21:129, 1968.

    PubMed  CAS  Google Scholar 

  65. Birkenhager JC, Upton GV: Meduallary thyroid carcinoma. Ectopic production of peptides with ACTH-like, CRF-like and prolactin production stimulating activity. Acta Endocrinol (Kbh) 83:280, 1976.

    CAS  Google Scholar 

  66. Melone CR, Tucci J, et al: Cushing’s syndrome due to bilateral adrenocortical hyperplasia caused by a benign adrenal medullary tumor. J Clin Endocrinol Metab 26:1192, 1966.

    Google Scholar 

  67. Spark RF, Connolly PB: ACTH secretion from a functioning pheochromocytoma. N Engl J Med 301:416, 1979.

    PubMed  CAS  Google Scholar 

  68. Howland WJ Jr, Pugh DG, Sprague RG: Roentgenologic changes of the skeletal system in Cushing’s syndrome. Radiology 71:69, 1958.

    PubMed  Google Scholar 

  69. Hahn TJ: Corticosteroid-induced osteopenia. Arch Intern Med 138:882 ,1978.

    PubMed  Google Scholar 

  70. Hahn TJ, Halstead LR, Baran DT: Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52:111, 1981.

    PubMed  CAS  Google Scholar 

  71. Findling JW, Adams ND, Lemann J, et al: Vitamin D metabolites and parathyroid hormone in Cushing’s syndrome: Relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab 54:1039, 1982.

    PubMed  CAS  Google Scholar 

  72. Teitelbaum SL, Malong JD, Kahn AJ: Glucocorticoid enhancement of bone resorption by rat peritoneal macrophages in vitro. Endocrinology 108:795, 1981.

    PubMed  CAS  Google Scholar 

  73. Jee WSS, Park HZ, Roberts WE, et al: Corticosteroid and bone. Am J Anat 129:477, 1970.

    PubMed  CAS  Google Scholar 

  74. Nosadini R, Del Prato A, Valerio TA, et al: Insulin resistance in Cushing’s syndrome. J Clin Endocrinol Metab 57:529, 1983.

    PubMed  CAS  Google Scholar 

  75. McArthur RG, Cloutier MD, Hayles AB, et al: Cushing’s disease in children. Mayo Clin Proc 47:318, 1972.

    PubMed  CAS  Google Scholar 

  76. Frantz AG, Rabkin MT: Human growth hormone: Clinical measurement, response to hypoglycemia and suppression by corticosteroids. N Engl J Med 271:1375, 1964.

    PubMed  CAS  Google Scholar 

  77. Vazquez AM, Schutt-Aine JC, Kenny FM, et al: Effect of cortisone therapy on the diurnal pattern of growth hormone secretion in congenital adrenal hyperplasia. J Pediatr 80:433, 1972.

    PubMed  CAS  Google Scholar 

  78. Sturge RA, Beardwell C, Hartog M, et al: Cortisol and growth hormone secretion in relation to linear growth: Patients with Still’s disease on different therapeutic regimens. Br Med J 3:547, 1970.

    PubMed  CAS  Google Scholar 

  79. Preece MA: The effect of administered corticosteroids on the growth of children. Postgrad Med J 52:625, 1976.

    PubMed  CAS  Google Scholar 

  80. Morris HG, Jorgensen JR, Elrick H, et al: Metabolic effects of human growth hormone in corticosteroid-treated children. J Clin Invest 47:436, 1968.

    PubMed  CAS  Google Scholar 

  81. Phillips LS, Belosky DC, Young HS, et al: Nutrition and somatomedin. VI. Somatomedin activity and somatomedin inhibitory activity in serum from normal and diabetic rats. Endocrinology 104:1519, 1979.

    PubMed  CAS  Google Scholar 

  82. Green OC, Winter RJ, Kawathara FS, et al: Pharmacokinetic studies of prednisolone in children: Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. J Pediatr 93:299, 1978.

    PubMed  CAS  Google Scholar 

  83. Elders MJ, Wingfield BS, McNatt ML, et al: Glucocorticoid therapy in children: effect on somatomedin secretion. Am J Dis Child 129:1393, 1975.

    PubMed  CAS  Google Scholar 

  84. Clark I, Umbreit W: Effect of cortisone and other steroids upon in vitro synthesis of chondrotin sulfate. Proc Soc Exp Biol Med 86:558, 1954.

    PubMed  CAS  Google Scholar 

  85. Phillips LS, Herington AC, Daughaday WH: Steroid hormone effects on somatomedin I. Somatomedin action in vitro. Endocrinology 97:780, 1975.

    PubMed  CAS  Google Scholar 

  86. Phillips LS, Fusco AC, Unterman TG, et al: Somatomedin inhibitor in uremia. J Clin Endocrinol Metab 59:764, 1984.

    PubMed  CAS  Google Scholar 

  87. Unterman TG, Phillips LS: Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 61:618, 1985.

    PubMed  CAS  Google Scholar 

  88. Bessler W: Vertebral growth arrest lines after Cushing’s syndrome. Case report. Diag Imaging 51:311, 1982.

    CAS  Google Scholar 

  89. Krieger DT, Allen W, Rizzo F, et al: Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32:266, 1971.

    PubMed  CAS  Google Scholar 

  90. Weitzman ED, Fukushima D, Nogeire C, et al: Twenty-four hour pattern of the episodic secretion of Cortisol in normal subjects. J Clin Endocrinol Metab 33:14, 1971.

    PubMed  CAS  Google Scholar 

  91. Crapo L: Cushing’s syndrome: A review of diagnostic tests. Metabolism 28:955, 1979.

    PubMed  CAS  Google Scholar 

  92. Nugent CA, Nichols T, Tyler FH: Diagnosis of Cushing’s syndrome-single dose dexamethasone suppression test. Arch Intern Med 116:172, 1965.

    PubMed  CAS  Google Scholar 

  93. McHardy-Young S, Harris PWR, Lessof MH, et al: Single-dose dexamethasone suppression test for Cushing’s syndrome. Br Med J 2:740, 1967.

    PubMed  CAS  Google Scholar 

  94. Tucci JR, Jagger PI, Lauler DP, et al: Rapid dexamethasone suppression tests for Cushing’s syndrome. JAMA 199:379, 1967.

    PubMed  CAS  Google Scholar 

  95. Seidensticker JF, Folk RL, Wieland RG, et al: Screening test for Cushing’s syndrome with plasma 11-hydroxycorticosteroids. JAMA 202:87, 1967.

    PubMed  CAS  Google Scholar 

  96. Meikle AW: Dexamethasone suppression tests: Usefulness of simultaneous measurement of plasma Cortisol and dexamethasone. Clin Endocrinol (Oxf) 16:401, 1982.

    CAS  Google Scholar 

  97. Meikle AW, Lagerquist LG, Tyler FH: Apparently normal pituitary-adrenal suppressibility in Cushing’s syndrome: Dexamethasone metabolism and plasma levels. J Lab Clin Med 86:472, 1975.

    PubMed  CAS  Google Scholar 

  98. Caro JF, Meikle AW, Check JH, et al: Normal suppression to dexamethasone in Cushing’s disease: An expression of decreased metabolic clearance for dexamethasone. J Clin Endocrinol Metab 47:667, 1978.

    PubMed  CAS  Google Scholar 

  99. Murphy BEP: Clinical evaluation of urinary Cortisol determinations by competitive proteinbinding radioassay. J Clin Endocrinol Metab 28:343, 1968.

    PubMed  CAS  Google Scholar 

  100. Eddy RL, Jones AL, Gilland PF, et al: Cushing’s syndrome: A prospective study of diagnostic methods. Am J Med 55:621, 1973.

    PubMed  CAS  Google Scholar 

  101. Daughaday WH, Mariz IK: Corticosteroid-binding globulin: Its properties and quantitation. Metabolism 10:936, 1961.

    CAS  Google Scholar 

  102. Trecan GV, Laudat MH, Thomopoulos JP, et al: Urinary free corticoids: Evaluation of their usefulness in diagnosis of Cushing’s syndrome. Acta Endocrinol (Copenh) 103:110,1983.

    Google Scholar 

  103. Hellman L, Nakada F, Curti J, et al: Cortisol is secreted episodically by normal man. J Clin Endocrinol Metab 30:411, 1970.

    PubMed  CAS  Google Scholar 

  104. Hellman L, Weitzman ED, Roffwarg H, et al: Cortisol is secreted episodically in Cushing’s syndrome. J Clin Endocrinol Metab 30:686, 1970.

    PubMed  CAS  Google Scholar 

  105. de Lacerda L, Kowarski AA, Migeon CJ: Integrated concentration and diurnal variation of plasma Cortisol. J Clin Endocrinol Metab 36:227, 1973.

    PubMed  Google Scholar 

  106. Zadik Z, de Lacerda L, Kowarski A: Evaluation of the 6-hour integrated concentration of Cortisol as a diagnostic procedure for Cushing’s syndrome. J Clin Endocrinol Metab 54:1072, 1982.

    PubMed  CAS  Google Scholar 

  107. Halbreich U, Zumoff B, Kream J, et al: The mean 1300–1600 h plasma Cortisol concentration as a diagnostic test for hypercortisolism. J Clin Endocrinol Metab 54:1262, 1982.

    PubMed  CAS  Google Scholar 

  108. Ernest I: Steroid excretion and plasma Cortisol in 41 cases of Cushing’s syndrome. Acta Endocrinol (Copenh) 51:511, 1966.

    CAS  Google Scholar 

  109. Nichols T, Nugent CA, Tyler FH: Steroid laboratory tests in the diagnosis of Cushing’s syndrome. Am J Med 45:116, 1968.

    Google Scholar 

  110. Streeten DHP, Stevenson CT, Dalakos TG, et al: The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives. J Clin Endocrinol Metab 29:1191, 1969.

    PubMed  CAS  Google Scholar 

  111. Liddle GW: Cushing’s syndrome. In Eisenstein AB (ed): The Adrenal Cortex ,ed. 1. Little, Brown, Boston, 1967, p. 523.

    Google Scholar 

  112. Doe RP, Vennes JA, Flink EB: Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing’s syndrome. J Clin Endocrinol Metab 20:253, 1960.

    PubMed  CAS  Google Scholar 

  113. Glass AR, Zavadil AP III, Halberg F, et al: Circadian rhythm of serum Cortisol in Cushing’s disease. J Clin Endocrinol Metab 59:161, 1984.

    PubMed  CAS  Google Scholar 

  114. Van Cauter E, LeClerq R, Van Haelst L, et al: Simultaneous study of Cortisol and TSH daily variations in normal subjects and patients with hyperadrenalcorticism. J Clin Endocrinol Metab 39:645, 1974.

    PubMed  Google Scholar 

  115. Mizutani S, Sonoda T, Seki T, et al: Excretion patterns of urinary 17-KS and 17-OHCS in patients with Cushing’s syndrome. Urol Int 29:341, 1974.

    PubMed  CAS  Google Scholar 

  116. Moolenaar AJ, Van Seters AP: Gas chromatographic determination of steroids in the urine of patients with Cushing’s syndrome. Acta Endocrinol 67:303, 1971.

    PubMed  CAS  Google Scholar 

  117. Phillipou G: Investigation of urinary steroid profiles as a diagnostic method in Cushing’s syndrome. Clin Endocrinol (Oxf) 16:433, 1982.

    CAS  Google Scholar 

  118. Liddle GW: Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 20:1539, 1960.

    PubMed  CAS  Google Scholar 

  119. Lamberts SWJ, de Jong FH, Birkenhager JC: Evaluation of diagnostic and differential diagnostic tests in Cushing’s syndrome. Neth J Med 20:267, 1977.

    PubMed  CAS  Google Scholar 

  120. Nichols T, Nugent CA, Tyler FH: Steroid laboratory tests in the diagnosis of Cushing’s syndrome. Am J Med 45:116, 1968.

    Google Scholar 

  121. Findling JW, Aron DC, Tyrell JB, et al: Selective venous sampling for ACTH in Cushing’s syndrome. Differentiation between Cushing’s disease and ectopic ACTH syndrome. Ann Intern Med 94:647, 1981.

    PubMed  CAS  Google Scholar 

  122. Linn JE, Bowdoin B, Farmer A, et al: Observations and comments on failure of dexamethasone suppression. N Engl J Med 277:403, 1967.

    PubMed  Google Scholar 

  123. Carey RM: Suppression of ACTH by Cortisol in dexamethasone-nonsuppressible Cushing’s disease. N Engl J Med 302:275, 1980.

    PubMed  CAS  Google Scholar 

  124. Lieberman B, Wajchenberg BL, Tambascia MA, et al: Periodic remission in Cushing’s disease with paradoxical dexamethasone response: An expression of periodic hormonogenesis. J Clin Endocrinol Metab 43:913, 1976.

    Google Scholar 

  125. Brown RD, Van Loon GR, Orth DN, et al: Cushing’s disease with periodic hormonogenesis. / Clin Endocrinol Metab 36:445, 1973.

    CAS  Google Scholar 

  126. Aron DC, Findling JW, Fitzgerald PA, et al: Pituitary ACTH dependency of nodular hyperplasia in Cushing’s syndrome. Report of two cases and review of the literature. Am J Med 71:302, 1981.

    PubMed  CAS  Google Scholar 

  127. Smalls AGH, Pieters GFFM, Van Haelst UJG, et al: Macronodular adrenocortical hyperplasia in long standing Cushing’s disease. J Clin Endocrinol Metab 58:25, 1984.

    Google Scholar 

  128. Mason AMS, Ratcliffe JG, Buckle RM, et al: ACTH secretion by bronchial carcinoid tumors. Clin Endocrinol (Oxf) 1:3, 1972.

    CAS  Google Scholar 

  129. Northrop G, Baldwin D, Faber LP, et al: Dexamethasone suppression of urinary 17-hydroxycorticoids in a patient with an ACTH-producing bronchial adenoma. Presbyterian-St. Lukes Med Bull 9:43, 1970.

    Google Scholar 

  130. Strott CA, Nugent CA, Tyler FH: Cushing’s syndrome caused by bronchial adenomas. Am J Med 44:97, 1968.

    PubMed  CAS  Google Scholar 

  131. Aron DC, Tyrell JB, Fitzgerald PA, et al: Cushing’s syndrome: Problems in diagnosis. Medicine (Baltimore) 60:25, 1981.

    CAS  Google Scholar 

  132. Gruen PH: Endocrine changes in psychiatric diseases. Med Clin North Am 62:285, 1978.

    PubMed  CAS  Google Scholar 

  133. Meikle AW, Jubiz W, Hutchings M, et al: Simplified metyrapone test with determination of plasma 11-deoxycortisol (metyrapone test with plasma S). J Clin Endocrinol Metab 23:985, 1969.

    Google Scholar 

  134. Spiger N, Jubiz W, Meikle AW, et al: Single dose metyrapone test. Review of a four-year experience. Arch Intern Med 135:698, 1975.

    PubMed  CAS  Google Scholar 

  135. Sindler BH, Griffing GT, Melby JC: The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing’s syndrome. Am J Med 74:657, 1983.

    PubMed  CAS  Google Scholar 

  136. Carballeira A, Fishman LM, Jacobi GD: Dual sites of inhibition by metyrapone of human adrenal steroidogenesis: Correlation of in vivo and in vitro studies J Clin Endocrinol Metab 42:687, 1976.

    PubMed  CAS  Google Scholar 

  137. Matthews JI, Fariss BB, Chertow BS, et al: Adrenal adenoma with variable response to dexamethasone. J Clin Endocrinol Metab 34:902, 1972.

    PubMed  CAS  Google Scholar 

  138. Vale W, Spiess J, Rivier C, et al: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394, 1981.

    PubMed  CAS  Google Scholar 

  139. Rivier C, Brownstein M, Spiess J, et al: In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, β-endorphin, and corticosterone. Endocrinology 110:272, 1982.

    PubMed  CAS  Google Scholar 

  140. Orth DN, DeBold CR, DeCherney GS: Pituitary microadenomas causing Cushing’s disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab 55:1017, 1982.

    PubMed  CAS  Google Scholar 

  141. Muller OA, Stalla GK, Werder K: Corticotropin releasing factor: A new tool for the differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 57:227, 1983.

    PubMed  CAS  Google Scholar 

  142. Chrousos GP, Schulte HM, Oldfield EH, et al: The corticotropin-releasing factor stimulation test-an aid in the evaluation of patients with Cushing’s syndrome. N Engl J Med 310:622, 1984.

    PubMed  CAS  Google Scholar 

  143. Pieters FFM, Hermus ARMM, Smals AGH: Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary dependent Cushing’s disease. J Clin Endocrinol Metab 57:513, 1983.

    PubMed  CAS  Google Scholar 

  144. Suda T, Tomori N, Tozawa F: Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing’s disease in vitro. J Clin Endocrinol Metab 59:840, 1984.

    PubMed  CAS  Google Scholar 

  145. Shibasaki T, Nakahara M, Shizume K, et al: Pituitary adenomas that caused Cushing’s disease or Nelson’s syndrome are not responsive to ovine corticotropin-releasing factor in vitro. J Clin Endocrinol Metab 56:414, 1983.

    PubMed  CAS  Google Scholar 

  146. Orth DN: The old and new in Cushing’s syndrome. N Engl J Med 310:649, 1984.

    PubMed  CAS  Google Scholar 

  147. Lytras N, Grossman A, Tomlin PS, et al: Corticotrophin releasing factor: Responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf) 20:71, 1984.

    CAS  Google Scholar 

  148. Meikle AW, Stanchfield JB, West CD, et al: Hydrocortisone suppression test for Cushing’s syndrome. Arch Intern Med 134:1068, 1974.

    PubMed  CAS  Google Scholar 

  149. Sachar EJ, Hellman L, Roffwarg HP, et al: Disrupted 24-hour patterns of Cortisol secretion in psychotic depression. Arch Gen Psychiatry 28:19, 1973.

    PubMed  CAS  Google Scholar 

  150. Carroll BJ, Curtis GC, Davies BM, et al: Urinary free Cortisol excretion in depression. Psychol Med 6:43, 1976.

    PubMed  CAS  Google Scholar 

  151. Butler PWP, Besser GM: Pituitary adrenal function in severe depressive illness. Lancet 1:1234, 1968.

    PubMed  CAS  Google Scholar 

  152. Chrousos GP: Clinical application of corticotropin-releasing factor (NIH Conference). Ann Intern Med 102:344, 1985.

    PubMed  CAS  Google Scholar 

  153. Frajria R, Angeli A: Alcohol-induced pseudo-Cushing’s syndrome. Lancet 1:1050, 1977.

    PubMed  CAS  Google Scholar 

  154. Jenkins RM, Page M McB: An atypical case of alcohol-induced cushingoid syndrome. Br Med J 282:1117, 1981.

    CAS  Google Scholar 

  155. Lamberts SWJ, Klinjn JGM, de Jong FH, et al: Hormone secretion in alcohol-induced pseudo-Cushing’s syndrome. JAMA 242:1640, 1979.

    PubMed  CAS  Google Scholar 

  156. James VHT, Landon J, Wynn U, et al: A fundamental defect of adrenocortical control in Cushing’s disease. J Endocrinol (Oxf) 40:15, 1968.

    CAS  Google Scholar 

  157. Yamaji T, Ishibashi M, Sekihara H, et al: Serum dehydroepiandrosterone Sulfate in Cushing’s syndrome. J Clin Endocrinol Metab 59:1164, 1984.

    PubMed  CAS  Google Scholar 

  158. Bailey RE: Periodic hormonogenesis: A new phenomena; periodicity in function of a hormone producing tumor in man. J Clin Endocrinol Metab 32:317, 1971.

    PubMed  CAS  Google Scholar 

  159. Jordan RM, Ramos-Gabatin A, Kendall JW, et al: Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing’s syndrome: Evidence for more than one abnormal ACTH biorhythm. J Clin Endocrinol Metab 55:531, 1982.

    PubMed  CAS  Google Scholar 

  160. Spark RF, Connolly PB: ACTH secretion from a functioning pheochromocytoma. N Engl J Med 301:416, 1979.

    PubMed  CAS  Google Scholar 

  161. Cook DM, Kendall JW: Cushing’s syndrome-current concepts of diagnosis and therapy. West J Med 132:111, 1980.

    PubMed  CAS  Google Scholar 

  162. Weyman PJ, Glazer HS: The adrenals. In Lee JKT, Sagel SS, Stanley RJ (eds): Computed Body Tomography. Raven, New York, 1983, p. 379.

    Google Scholar 

  163. White FE, White MC, Drury PL, et al: Value of computed tomography of the abdomen and chest in investigation of Cushing’s syndrome. Br Med J 284:771, 1982.

    CAS  Google Scholar 

  164. Chambers EF, Turski PA, LaMasters D: Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 144:109, 1982.

    PubMed  CAS  Google Scholar 

  165. Davis PC, Hoffman JC Jr, Tindall GT, et al: Prolactin-secreting pituitary microadenomas: inaccuracy of high presolution CT imaging. AJNR 5:721, 1984.

    Google Scholar 

  166. Green HT: The venous drainage of the human hypophysis cerebri. Am J Anat 100:435, 1957.

    PubMed  CAS  Google Scholar 

  167. Oldfield EH, Girton ME, Doppman JL: Absence of intercavernous venous mixing: evidence supporting lateralization of pituitary microadenomas by venous sampling. J Clin Endocrinol Metab 61:644, 1985.

    PubMed  CAS  Google Scholar 

  168. Kley HK, Stolze T, Kruskemper HL: Jugular-vein sampling of ACTH. N Engl J Med 297:731, 1977.

    Google Scholar 

  169. Corrigan DF, Schaaf M, Whaley RA, et al: Selective venous sampling to differentiate ectopic ACTH secretion from pituitary Cushing’s syndrome. N Engl J Med 296:861, 1977.

    PubMed  CAS  Google Scholar 

  170. Oldfield EH, Chrousos GP, Schulte HM, et al: Preoperative localization of ACTH secreting microadenomas by bilateral and simultaneous inferior petrosal sinus sampling. N Engl J Med 312:100, 1985.

    PubMed  CAS  Google Scholar 

  171. Manni A, Latshaw RF, Page R, et al: Simultaneous bilateral venous sampling for adrenocorticotropin in pituitary-dependent Cushing’s disease: evidence for lateralization of pituitary venous drainage. J Clin Endocrinol Metab 57:1070, 1983.

    PubMed  CAS  Google Scholar 

  172. Smyth HS: Pituitary basophilism. Microsurgical observations on the pathogenesis of Cushing’s disease. In Workshop on Pituitary Pathology. Second Meeting of the International Pituitary Pathology Club, Oaxtepec, Morelos, Mexico, June 19–22, 1984 ,p. 3.

    Google Scholar 

  173. Styne DM, Grumbach MM, Kaplan SL, et al: Treatment of Cushing’s disease in childhood and adolescence by transsphenoidal microadenomectomy. N Engl J Med 310:889, 1984.

    PubMed  CAS  Google Scholar 

  174. Pont A, Gutierrez-Hartman A: Cushing’s disease: recurrence after a surgically induced remission. Arch Intern Med 139:938, 1979.

    PubMed  CAS  Google Scholar 

  175. McNichol AM: Patterns of corticotropic cells in the adult human pituitary in Cushing’s disease. Diag Histopathol 4:335, 1981.

    Google Scholar 

  176. Schnall AM, Kovacs K, Brodkey JS, et al: Pituitary Cushing’s disease without adenoma. Acta Endocrinol 94:297, 1980.

    PubMed  CAS  Google Scholar 

  177. Ludecke D, Kautzky R, Saeger W, et al: Selective removal of hypersecreting pituitary adenomas. Acta Neurochir 35:27, 1976.

    CAS  Google Scholar 

  178. Nelson DH, Meakin JW, Thorn GW: ACTH-producing pituitary tumors following adrenalectomy for Cushing’s syndrome. Ann Intern Med 52:560, 1960.

    PubMed  CAS  Google Scholar 

  179. Cook DM, Kendall JW, Allen JP, et al: Nycothemeral variation and suppressibility of plasma ACTH in various stages of Cushing’s disease. Clin Endocrinol (Oxf) 5:303, 1976.

    CAS  Google Scholar 

  180. Moore TJ, Dluhy RG, Williams GH, et al: Nelson’s syndrome: Frequency, prognosis, and effect of prior irradiation. Ann Intern Med 85:731, 1976.

    PubMed  CAS  Google Scholar 

  181. Jennings AS, Liddle GW, Orth DN: Results of treating childhood Cushing’s disease with pituitary irradiation. N ENgl J Med 297:957, 1977.

    PubMed  CAS  Google Scholar 

  182. Barnett AH, Livesey JH, Friday K, et al: Comparison of preoperative and postoperative ACTH concentrations after bilateral adrenalectomy in Cushing’s disease. Clin Endocrinol (Oxf) 18:301, 1983.

    CAS  Google Scholar 

  183. Krieger DT, Amorosa L, Linick F: Cyproheptadine-induced remission of Cushing’s disease. N Engl J Med 293:893, 1975.

    PubMed  CAS  Google Scholar 

  184. Krieger DT: Cyproheptadine: Drug therapy for Cushing’s disease. In Muller EE (ed): Neuroactive Drugs in Endocrinology. Elsevier/North-Holland, Amsterdam, 1980, p. 361.

    Google Scholar 

  185. Lamberts SWJ, Birkenhager JC: Bromocriptine in Nelson’s syndrome and Cushing’s disease. Lancet 2:811, 1976.

    PubMed  CAS  Google Scholar 

  186. Miura K, Aida M, Mihara A, et al: Treatment of Cushing’s disease with reserpine and pituitary radiation. J Clin Endocrinol Metab 41:511, 1975.

    PubMed  CAS  Google Scholar 

  187. Elias AN, Gwinup G, Valenta LJ: Effects of valproic acid, naloxone and hydrocortisone in Nelson’s syndrome and Cushing’s syndrome. Clin Endocrinol (Oxf) 15:151, 1981.

    CAS  Google Scholar 

  188. Dornhorst A, Jenkins JS, Lamberts SWJ, et al: The evaluation of sodium valproate in the treatment of Nelson’s syndrome. J Clin Endocrinol Metab 56:985, 1983.

    PubMed  CAS  Google Scholar 

  189. Jones MT, Gillham B, Beckford U: Effect of treatment with sodium valproate and diazepam on plasma corticotropin in Nelson’s syndrome. Lancet 1:1179, 1981.

    PubMed  CAS  Google Scholar 

  190. Gomi M, Iida S, Itoh Y, et al: Unaltered stimulation of pituitary adrenocorticotrophin secretion by corticotrophin releasing factor following sodium valproate administration in a patient with Nelson’s syndrome. Clin Endocrinol (Oxf) 23:123, 1985.

    CAS  Google Scholar 

  191. Sonino N, Boscaro M, Merola G, et al: Prolonged treatment of Cushing’s disease by ketoconazole. J Clin Endocrinol Metab 61:718, 1985.

    PubMed  CAS  Google Scholar 

  192. Beierwaltes WH, Wieland DM, Yu T, et al: Adrenal imaging agents: Rationale, synthesis, formulation and metabolism. Semin Nucl Med 8:5, 1978.

    PubMed  CAS  Google Scholar 

  193. Thrall JH, Freitas JE, Beierwaltes WH: Adrenal scintigraphy. Semin Nucl Med 8:23, 1978.

    PubMed  CAS  Google Scholar 

  194. Anderson DC, Child DF, Sutcliffe CH, et al: Cushing’s syndrome, nodular hyperplasia and virilizing carcinoma. Clin Endocrinol (Oxf) 9:1, 1978.

    CAS  Google Scholar 

  195. Tyrrell JB, Findling JW, Aron DC, et al: An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing’s syndrome. Ann Intern Med 104:180, 1986.

    PubMed  CAS  Google Scholar 

  196. Gold PW, Loriaux DL, Roy A, et al: Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing’s disease. N Engl] Med 314:1329, 1986.

    CAS  Google Scholar 

  197. Findling JW, Tyrrell JB: Occult ectopic secretion of corticotropin. Arch Intern Med 146:929, 1986.

    PubMed  CAS  Google Scholar 

  198. Mellinger RC: The conundrum of Cushing’s syndrome. Arch Intern Med 146:858, 1986.

    PubMed  CAS  Google Scholar 

  199. Adelman S: The Pathology of Pituitary Adenomas. In Post KD, Jackson IM, Reichlin S (eds): The Pituitary Adenoma ,Plenum Press, New York, 1980, pp. 47–62.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism Department of Medicine, Cook County Hospital, Chicago, Illinois, USA

    C. R. Kannan M.D. (Chairman, Clinical Associate Professor of Medicine)

  2. University of Illinois at Chicago, Chicago, Illinois, USA

    C. R. Kannan M.D. (Chairman, Clinical Associate Professor of Medicine)

Authors
  1. C. R. Kannan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Publishing Corporation

About this chapter

Cite this chapter

Kannan, C.R. (1987). Cushing’s Disease. In: The Pituitary Gland. Clinical Surveys in Endocrinology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1849-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1849-1_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9032-2

  • Online ISBN: 978-1-4613-1849-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation